For the roughly 37 million Americans living with type 2 diabetes, glycemic control often hinges on factors far upstream of medication — including whether nutritious food is reliably accessible. A well-designed randomized controlled trial now offers some of the strongest evidence to date that structured food provisioning, not just dietary counseling, can move the clinical needle in a high-risk, food-insecure population.
Published in Circulation, this three-arm trial enrolled 460 Medicaid-insured adults in southern California with persistently elevated hemoglobin A1c (≥7.5% on at least two recent measurements; mean baseline HbA1c 9.40%). Participants were predominantly Hispanic women with a mean age of 59 years, and 58% reported food insecurity at enrollment. Over six months, participants were randomized to usual care or one of two doses of medically tailored groceries (MTG) — weekly home deliveries of health-promoting produce scaled to household size, paired with matched recipes and telenutrition counseling. The lower-dose arm received groceries valued at roughly $100–$170 per month; the higher-dose arm received $135–$210 per month. The prespecified primary endpoint was change in HbA1c at six months, with secondary outcomes including food security, nutrition security, hypertension, and BMI.
This trial addresses a critical gap: while observational data have long linked food insecurity to poor diabetes outcomes, randomized evidence for food-as-medicine programs has been sparse. The cohort's demographic profile — largely low-income, Hispanic, and female — reflects the populations bearing the greatest diabetes burden, lending practical relevance to the findings. Key limitations include the six-month timeframe, which may underestimate long-term metabolic benefit or participant fatigue, and the single-region design limiting geographic generalizability. Dose-response comparisons between MTG arms will be critical for understanding cost-effectiveness. If effects are confirmed at scale, this model could challenge the dominant medication-first paradigm and inform Medicaid coverage policy for food interventions — an editorial finding of potentially paradigm-shifting significance for nutritional medicine.
